Addyi® is the #1 prescribed treatment for HSSD1 (Hypoactive Sex Drive) in women who have not gone through menopause. Who has not had problems with low sexual desire in the past, and who has common sexual desire no matter the type of sexual activity, the situation, or their sexual partner?
Women with HSDD have a low sexual desire that is troubling to them. Their intense sexual desire is not due to: a medical or mental health problem, problems in the relationship, medicine, or other drug use.
In clinical trials, some women have experienced notable improvements in one or more of their HSDD symptoms, including increased satisfying sexual events such as sexual intercourse, oral sex, masturbation, or genital stimulation by a partner.
Not approved Addyi® for treating HSDD in males, children, or postmenopausal women. ADDYI is not for use to enhance sexual performance.
We at Alma MedSpa in Missouri can help you with sexual health treatments in St.Peters for both men and women. Our team of experts will
Women typically continue medication for two to three years to alleviate the symptoms of menopause and other hormonal changes. If you are pleased with the outcomes, you can continue with treatment indefinitely.
Many women experience weight gain and water retention after their first BHRT pellet insertion. That's because testosterone promotes muscle growth, and that, in turn, induces fluid retention. A weight gain of 2 to 5 pounds is possible.
It is up to the individual and their health and anti-aging goals to determine how long they should continue BHRT. Still, we can guarantee the vast majority of our patients that it is a treatment that may be safely continued indefinitely.
According to clinical trial data, they may not fully realize flibanserin's effects until eight to twelve weeks after treatment has begun.
Addyi can cause various unwanted effects, the most prevalent of which are lightheadedness, nausea, exhaustion, insomnia, and dry mouth.